Functional inhibition of CHK1, via the pharmacological inhibitor UCN-01 or gene silencing with short hairpin RNA (shRNA) targeting CHK1, sensitized gastric cancer cells to radiation and bleomycin, further supporting its role as a modulator of therapeutic resistance. Here, CHEK1 is linked to gastric cancer.